Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TEL AVIV, Israel and WHITE PLAINS, N.Y., May 30, 2013 (GLOBE NEWSWIRE) -- Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-producing cells as a treatment for diabetes, is pleased to announce that it will be presenting updates on the Company’s business and technology at two key conferences in the month of June.
Help employers find you! Check out all the jobs and post your resume.
